AbCellera Presents Data on T-Cell Engagers Against Four Tumor Targets at AACR 2024
AbCellera Biologics Inc. - Common Shares (ABCL)
Company Research
Source: Business Wire
Data show how AbCellera is expanding the reach of T-cell engagers with:CD3-binding antibodies that consistently generate T-cell engagers with potent tumor-cell killing and low cytokine release across multiple tumor targets, including PSMA, B7-H4, and 5T4Costimulatory CD28-binding antibodies that stimulate T cells without superagonist activityHighly specific T-cell engagers for the peptide-MHC target MAGE-A4 VANCOUVER, British Columbia--(BUSINESS WIRE)--AbCellera (Nasdaq: ABCL) today announced new data on its T-cell engager (TCE) programs at the American Association for Cancer Research? (AACR) Annual Meeting 2024 at the San Diego Convention Center, with three posters being presented on April 8 and one on April 9. Together, AbCellera’s data demonstrate that it is well-positioned to advance TCEs as a drug class by widening the therapeutic window, enhancing potency, and broadening the accessible target space.“TCEs are among the most promising new modalities in cancer therapy, but limit
Show less
Read more
Impact Snapshot
Event Time:
ABCL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABCL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABCL alerts
High impacting AbCellera Biologics Inc. - Common Shares news events
Weekly update
A roundup of the hottest topics
ABCL
News
- Sky bridge to connect new state-of-the-art research facility to Vancouver's St. Paul's hospital [Globe and Mail, The (Toronto, Canada)]Globe and Mail, The
- AbCellera Presents Data on T-Cell Engagers Against Four Tumor Targets at AACR 2024 [Yahoo! Finance]Yahoo! Finance
- AbCellera to Report First Quarter 2024 Financial Results on May 7, 2024Business Wire
- AbCellera to Present at the Bloom Burton Healthcare Conference on April 16, 2024 [Yahoo! Finance]Yahoo! Finance
- AbCellera to Present at the Bloom Burton Healthcare Conference on April 16, 2024Business Wire
ABCL
Earnings
- 2/20/24 - Miss
ABCL
Sec Filings
- 4/29/24 - Form ARS
- 4/29/24 - Form DEFA14A
- 4/29/24 - Form DEF
- ABCL's page on the SEC website